MedPath

TESTOSTERONE CYPIONATE INJECTION USP

TESTOSTERONE CYPIONATE INJECTION USP

Discontinued
DIN Number

02246063

Drug Class

Human

Market Date

Aug 1, 2002

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02246063
AIG Number0106401001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule G (CDSA IV)
A
ATC Code
G03BA03 TESTOSTERONE
Product Specifications
Dosage FormLiquid
Route of AdministrationIntramuscular
AHFS Classification68:08.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

TESTOSTERONE CYPIONATEActive
Strength: 100 MG / ML
Monograph: TESTOSTERONE CYPIONATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.